韩洁,刘宝,万珊,杨焕婕,费樱
HAN Jie,LIU Bao,WAN Shan,YANG Huanjie,FEI Ying

• 1:贵州医科大学
• 2:贵州医科大学附院微生物免疫科

摘要(Abstract)：

目的:了解贵阳市某三甲医院鲍曼不动杆菌的临床科室分布及耐药性的变迁。方法:对2008-2014年贵阳市某三甲医院临床送检标本进行细菌鉴定和药敏试验,分析鲍曼不动杆菌检出率、主要标本来源、科室分布及对临床常用抗菌药物的耐药情况。结果:7年内共检出3 463株鲍曼不动杆菌,以分泌物中鲍曼不动杆菌的检出率最高,占12.15%;鲍曼不动杆菌的科室分布以重症监护室(ICU)和外科为主,分别占44.42%和33.15%;药敏结果显示,鲍曼不动杆菌对各类抗生素的耐药率表现为逐年升高,对亚胺培南、左氧氟沙星和替卡西林-克拉维酸耐药性升高最为明显。结论:鲍曼不动杆菌的临床检出率较高,该细菌耐药率呈逐年增加趋势,特别是对碳青霉烯类药物有较高耐药率。
Objective: To investigate the clinical department distribution and drug resistance change of A. baumanii isolated from Jan 2008 to Dec 2014. Methods: The Microscan walkaway 40 SI was used for identifying bacteria and drug susceptibility testing. Detection rates of A. baumanii,main specimen source,distribution of clinical department and drug resistance were analyzed. Results: A total of3 463 clinical strains of A. baumanii were isolated during seven years. Detection rate of A. baumanii in the secretion was 12. 15%,which is the highest during all specimens. A. baumanii strains was mainly distributed in ICU and surgery,accounting for 44. 2% and 33. 15%,respectively. The results of drug sensitive test showed that the rate of antibiotic resistance increased steadily year by year,especially obvious in resistance to imipenem,levofloxacin and ticarcillin / clavulanic acid. Conclusion: The clinical detection rate of A. baumanii is high. Drug resistance rates of A. baumanii to antibiotics increase year by year,especially to carbapenemase antibiotics.

关键词(KeyWords)： 鲍曼不动杆菌;感染;统计学分布;耐药性;抗生素类
Acinetobactor baumanii;infection;statistical distribution;drug resistance;antibiotics

Abstract:

Keywords:

基金项目(Foundation): 贵州省科技厅基金资助项目[黔科合SY字(2012)3147]

作者(Author): 韩洁,刘宝,万珊,杨焕婕,费樱
HAN Jie,LIU Bao,WAN Shan,YANG Huanjie,FEI Ying

DOI: 10.19367/j.cnki.1000-2707.2016.02.021

参考文献(References)：

• [1]陈海红,李华茵,何礼贤,等.耐碳青烯类鲍曼不动杆菌的耐药机制研究进展[J].中国呼吸与危重监护杂志,2010(4):439-443.
• [2]王辉,郭萍,孙宏莉,等.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中国检验医学杂志,2006(12):1066-1070.
• [3]汪复,朱德妹,胡付品,等.2012年中国CHINET细菌耐药性监测[J].中国感染与化学杂志,2013(5):321-330.
• [4]叶应妩,王毓三,申子瑜.全国临床检验操作规程[M].3版.南京:东南大学出版社,2006:357-360.
• [5]中华医学会.抗菌药物敏感性试验执行标准[J].中华检验医学杂志,2013(1):21-23.
• [6]李美,刘宝,万珊,等.2008-2012年临床分离阴沟肠杆菌的分布及耐药性分析[J].中国抗生素杂志,2014(10):775-779.
• [7]罗鹏,戴玮,张莉萍.1 582株鲍曼不动杆菌的临床分布及耐药性分析[J].重庆医学,2011(3):224-226.
• [8]陈柳勤,孙诚,张莉滟,等.238株鲍曼不动杆菌感染状况及耐药性分析[J].实用医学杂志,2009(16):2768-2770.
• [9]何林林,李京明,刘双,等.鲍曼不动杆菌在ICU与非ICU分离率及耐药性的比较[J].实用医学杂志,2010(1):125-126.
• [10]孙海平,林宁,郑玉龙,等.鲍曼不动杆菌下呼吸道医院感染流行性及耐药性分析[J].江苏医药,2011(4):436-438.
• [11]吕美艳,周翠,徐琦煜,等.161株鲍曼不动杆菌OXA-23基因组介导的耐药性和同源性分析[J].中国卫生检验杂志,2011(2):412-415.
• [12]张伟红,叶慧芬,杨银梅,等.耐亚胺培南鲍曼不动杆菌耐药表型和碳青霉烯酶基因型分析[J].中国感染与化疗杂志,2011(1):45-48.
• [13]孙诚,陈柳勤,叶珩,等.2007-2011年重症监护病房鲍曼不动杆菌的耐药性变迁[J].实用医学杂志,2012(14):2370-2372.
• [14]杨健,江培涛,杨正南,等.2008-2012年鲍曼不动杆菌感染分布特征及耐药性变迁[J].检验医学与临床,2013(21):2874-2875.

文章评论(Comment)：